Overview

Single and Multiple Ascending Dose Pharmacokinetic Study of TR701 in Healthy Adults

Status:
Completed
Trial end date:
2008-06-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of single rising oral doses and multiple oral doses of TR-701
Phase:
Phase 1
Details
Lead Sponsor:
Trius Therapeutics LLC
Treatments:
Linezolid
Torezolid phosphate